Seattle, WA, United States of America

Shawn Yu

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Inventor Shawn Yu

Introduction

Shawn Yu is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he has made remarkable strides in the design of interleukin mimetics, which have potential applications in therapeutic treatments.

Latest Patents

Shawn Yu's latest patents include the de novo design of potent and selective interleukin mimetics. These patents disclose de novo designed polypeptides that bind to the IL-2 receptor β heterodimer (IL-2Rβ), IL-4 receptor α heterodimer (IL-4Rα), and IL-13 receptor α subunit (IL-13Rα). Additionally, he has developed methods for using and designing these polypeptides. Another significant patent involves de novo designed polypeptides that bind to the IL-2 receptor βγ heterodimer (IL-2Rβγ), IL-4 receptor αγ heterodimer (IL-4Rαγ), and IL-13 receptor α subunit (IL-13Rα), along with methods for their application.

Career Highlights

Throughout his career, Shawn Yu has worked with esteemed institutions such as the University of Washington and Stanford University. His work has been instrumental in advancing the understanding and application of interleukin mimetics in medical science.

Collaborations

Shawn has collaborated with notable colleagues, including Daniel Adriano Silva Manzano and Umut Ulge, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Shawn Yu's innovative work in the design of interleukin mimetics showcases his expertise and dedication to advancing biotechnology. His contributions are paving the way for future developments in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…